No "back to normal" after COVID-19 for our failed drug policies.
Int J Drug Policy
; 83: 102901, 2020 09.
Article
in English
| MEDLINE | ID: covidwho-704616
ABSTRACT
Before COVID-19 pandemic, advocates had long urged drug policy reforms based on health, security, civil rights, racial justice, fiscal stewardship, and other considerations. In the United States, such calls went largely unanswered. In response to COVID-19, public health and occupational safety concerns have rapidly transformed some drug policies, along with their enforcement. Almost contemporaneously, nationwide protests against violence and racism by militarized police have highlighted the enduring legacy of the Drug War in fueling carceral systems. Disruption from these historical events provides a once-in-a-century opportunity to reconsider the legal architecture of drug policy and policing-both in the U.S. and elsewhere. Rather than returning to a fundamentally broken and inequitable status quo, we urge envisioning a new drug policy in service to life, liberty, and the pursuit of happiness.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Substance-Related Disorders
/
Law Enforcement
/
SARS-CoV-2
/
COVID-19
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Int J Drug Policy
Journal subject:
Public Health
/
Substance-Related Disorders
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS